The effect of percutaneous oestradiol on atheroma formation in ovariectomized cholesterol-fed rabbits

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 369-375

  Haines, Christopher J ^a   James, Anthony E ^a   Panesar, Nirmal S ^a   Ngai, Therese J ^a   Sahota, Daljit S ^a   Jones, Robert L ^a   Chang, Allan M Z ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Atherosclerosis; Cholesterol; Oestrogen

Indexed keywords

ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROMA; CHOLESTEROL BLOOD LEVEL; FEMALE; HORMONAL REGULATION; LIPID COMPOSITION; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, ORAL; ANIMALS; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; FEMALE; HYPERCHOLESTEROLEMIA; INJECTIONS, SUBCUTANEOUS; OVARIECTOMY; RABBITS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC;

EID: 0032895642     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00327-X     Document Type: Article

References (35)

1. Burger H. The menopausal transition. Bailliere's Clin Obstet Gynaecol. 10:1996;347-359.
2. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 20:1991;47-63.
3. Keaney J.F. Jr, Vita J.A. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasc Dis. 38:1995;129-154.
4. Ganger K.F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 338:1991;839-842.
5. US National Institutes of Health. NIH Publication No. 85-23, revised 1996.
6. Rao V.B., Rao H.V. Neural Networks and Fuzzy Logic. 1st edn:1995;271-305 MIS Press, New York.
7. Wilson R.B., Miller R.A., Middleton C.C., Kinden D. Atherosclerosis in rabbits fed a low cholesterol diet for 5 years. Atherosclerosis. 2:1982;228-241.
8. Haines C.J., Chung T.K.H., Masarei J.R.L., Tomlinson B., Lau J.T.F. The effect of percutaneous oestrogen replacement therapy on Lp(a) and other lipoproteins. Maturitas. 22:1995;219-225.
9. Haines C.J., Chung T.K.H., Chang A., Masarei J., Tomlinson B., Wong E. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women. Arch Intern Med. 156:1996;866-872.
10. Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., Wing R.R. Menopause and risk factors for coronary heart disease. New Engl J Med. 321:1989;641-646.
11. Walsh B.W., Schiff I., Rosner B., Greenberg L., Raunikav V., Sacks F.M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. New Engl J Med. 325:1991;1196-1204.
12. Van Leusden H.A., Albertyn G., Verlaine C., Van Ruymbeke J. A comparative multicenter study of two transdermal estradiol replacement therapies in the treatment of postmenopausal symptoms. Int J Fertil Menopausal Stud. 38:1993;210-218.
13. Dupont A., Dupont P., Cusan L., Tremblay M., Rioux J., Cloutier D., Maillox J., De Lignieres B., Gutkowska J., Boucher H., Belanger A., Moyer D.L., Moorjani S., Labrie F. Comparitive endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women. Maturitas. 13:1991;297-311.
14. Castelo-Branco C., Pons F., Gonzalez-Merlo J. Bone mineral density in surgically postmenopausal women receiving hormonal replacement therapy as assessed by dual photon absorptiometry. Maturitas. 16:1993;133-137.
15. Riis B.J., Thomsen K., Strom V., Christiansen C. The effect of percutaneous estradiol and natural progesterone on postmenopausal bone loss. Am J Obstet Gynecol. 156:1987;61-65.
16. De Lignieres B., Basdevant A., Thomas G., Thalabard J.C., Mercier-Bodard C., Conard J., Guyene T.T., Mairon N., Corvol P., Guy-Grand B. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab. 62:1986;536-541.
17. Basdevant A., De Lignieres B., Simon P., Blache D., Ponsin G., Guy-Grand B. Hepatic lipase activity during oral and parenteral 17β-estradiol replacement therapy: high-density lipoprotein increase may not be atherogenic. Fertil Steril. 55:1991;1112-1117.
18. Moorjani S., Dupont A., Labrie F., Lupien P.J., Gagne C., Brun D., Giguere M., Belanger A., Cusan L. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with Utrogestan in menopausal women. J Clin Endocrinol Metab. 73:1991;373-379.
19. Jensen J., Riis B.J., Strom V., Nilas C., Christiansen C. Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol. 156:1987;66-71.
20. Chetkowski R.J., Meldrum D.R., Steingold K.A., Randle D., Lu J.K., Eggena P., Hershman J.M., Alkjaersig N.K., Fletcher A.P., Judd H.L. Biologic effects of transdermal estradiol. New Engl J Med. 314:1986;1615-1620.
21. Stanczyk F.Z., Shoupe D., Nunez V., Macias-Gonzales P., Vijod M.A., Lobo R.A. A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol. 159:1988;1540-1546.
22. Pick R., Stamler J., Rodband S., Katz L.N. Inhibition of coronary atherosclerosis by estrogen in cholesterol-fed chickens. Circulation. 6:1952;276-281.
23. Moskowitz M.S., Moskowitz A.A., Bradford W.L. Changes in serum lipids and coronary arteries of the rat in response to estrogen. Arch Pathol. 61:1956;245-263.
24. Prichard R.W., Clarkson T.B., Lofland H.B. Estrogen in pigeon atherosclerosis; estradiol valerate at several dose levels on cholesterol-fed male white Carneau pigeons. Arch Pathol. 82:1966;15-27.
25. Clarkson T.B. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys. Fertil Steril. 62:1994;147S-151S.
26. 2 in ovariectomized monkeys. Lack of effect of added progestogens. Atherosclerosis. 10:1990;1051-1057.
27. Skjaerlund M. Estrogen protection against atherosclerosis and synthetic estrogen production of cirrhosis in the rabbit. Res Commun Chem Pathol Pharmacol. 75:1992;193-208.
28. Haarbo J., Leth-Espensen P., Stender S., Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 87:1991;1274-1279.
29. Hanke H., Hanke S., Finking G., Muhic-Lohrer A., Muck A.O., Schmahl F.W., Haasis R., Hombach V. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Circulation. 94:1996;175-181.
30. Hanke S., Bruck B., Gugel N., Finking G., Muck A.O., Schmahl F.W., Hombach V., Haasis R. Inhibition of the protective effect of estrogen by progesterone in experimental atherosclerosis. Atherosclerosis. 121:1996;129-138.
31. Adams M.R., Kaplan J.R., Clarkson T.B., Korotnik D.R. Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis. 5:1985;192-200.
32. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, Berglund L, et al. Oestrogen-induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterol-fed rabbit. Eur J Clin Invest 1989;19:395-403.
33. Hough J.L., Zilversmit D.B. Effect of 17-beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 6:1986;57-63.
34. Kushwaha R.S., Hazzard W.R. Exogenous estrogens attenuate dietary hypercholesterolaemia and atherosclerosis in the rabbit. Metabolism. 30:1981;359-367.
35. Haarbo J., Nielsen L.B., Stender S., Christiansen C. Aortic permeability to LDL during estrogen therapy. A study in normocholesterolemic rabbits. Arterioscler Thromb. 14:1994;243-247.